Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 17, 2024

BUY
$46.28 - $75.01 $5.1 Million - $8.26 Million
110,113 New
110,113 $7.6 Million
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $119,726 - $194,050
2,587 Added 2.41%
110,113 $7.6 Million
Q1 2023

May 17, 2024

BUY
$43.42 - $57.37 $4.67 Million - $6.17 Million
107,526 New
107,526 $5.18 Million
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $4.67 Million - $6.17 Million
107,526 New
107,526 $5.18 Million
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $1.51 Million - $2.26 Million
39,603 Added 106.97%
76,624 $3.13 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $55.0 $1.24 Million - $2.04 Million
37,021 New
37,021 $2.04 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.